Division of Nuclear Medicine, Russell H. Morgan Department of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
J Nucl Med. 2012 Jun;53(6):887-93. doi: 10.2967/jnumed.111.099325. Epub 2012 May 4.
Impaired global myocardial flow reserve (MFR) may be associated with increased risk for cardiac events and coronary artery disease progression. Chronic kidney disease (CKD) is also considered a risk factor for cardiovascular disease. We sought to investigate the effect of CKD on the myocardial microcirculation in patients referred for clinical (82)Rb PET/CT, who had normal left ventricular (LV) function and no flow-limiting coronary artery disease.
Estimated glomerular filtration rate (eGFR) was available for 230 patients who had undergone rest and pharmacologic stress (82)Rb PET/CT for suspected coronary artery disease. CKD was defined as an eGFR less than 60 mL/min/1.73 m(2). After patients with hemodialysis, a renal transplant, abnormal regional perfusion (summed stress score > 4), or reduced LV function (LV ejection fraction < 45%) were excluded, 40 CKD patients remained. Those were compared with a control group without CKD, which was matched for age, sex, coronary risk factors, and systemic hemodynamics (n = 42). List-mode acquisition of PET enabled quantification of myocardial blood flow (MBF) and MFR using a previously validated retention model with correction for (82)Rb extraction. Rest MBF was normalized to rate-pressure product.
Mean eGFR in the CKD group was reduced (44 ± 14 vs. 99 ± 28 mL/min/1.73 m(2); P < 0.0001), and creatinine was significantly elevated, compared with controls (1.9 ± 1.1 vs. 0.8 ± 0.2 mg/dL; P < 0.0001). MFR was significantly reduced in CKD (2.2 ± 1.0 vs. 3.0 ± 1.2 for controls; P = 0.027). This reduction was mainly due to increased rest MBF (1.1 ± 0.4 in CKD vs. 0.8 ± 0.2 mL/min/g in controls; P = 0.007). Stress myocardial flow was comparable between both groups (2.3 ± 0.9 vs. 2.3 ± 0.8 mL/min/g; P = 0.08). Overall, MFR was significantly correlated with eGFR (r = 0.41; P = 0.0005). Stress MBF did not correlate with eGFR (r = 0.002; P = 0.45), but rest MBF showed an inverse correlation (r = -0.49; P < 0.0001). Rest MBF was also inversely correlated with hemoglobin (r = -0.28; P = 0.014), but only eGFR was an independent correlate at multivariate analysis.
MFR is impaired in patients with renal insufficiency with normal regional perfusion and LV function, mostly because of elevated rest flow. Absolute quantification of flow may be useful to identify microvascular dysfunction as a precursor of clinically overt coronary disease in this specific risk group.
探讨慢性肾脏病(CKD)患者静息及药物负荷状态下的心肌血流储备(MFR)。方法:对 230 例行 82Rb-PET/CT 检查的可疑冠心病患者进行分析,记录左心室射血分数(LVEF)、肾小球滤过率(eGFR)等参数。排除行血液透析、肾移植、异常节段性灌注(总和应激评分>4)或左心室功能降低(LVEF<45%)的患者,最终 40 例 CKD 患者和 42 例 eGFR 正常的对照组患者纳入研究。采用列表模式采集 PET 数据,采用经过验证的滞留模型对心肌血流(MBF)和 MFR 进行定量分析,该模型可校正 82Rb 的提取。将静息 MBF 与心率血压乘积进行归一化。结果:CKD 组患者 eGFR 降低[(44±14)ml/min/(1.73m2)比(99±28)ml/min/(1.73m2),P<0.0001],血肌酐明显升高[(1.9±1.1)mg/dl 比(0.8±0.2)mg/dl,P<0.0001]。与对照组相比,CKD 患者 MFR 降低[(2.2±1.0)比(3.0±1.2),P=0.027],主要原因是静息 MBF 增加[(1.1±0.4)ml/min/g 比(0.8±0.2)ml/min/g,P=0.007]。两组患者的应激心肌血流无差异[(2.3±0.9)比(2.3±0.8)ml/min/g,P=0.08]。MFR 与 eGFR 呈显著正相关(r=0.41,P=0.0005),而应激 MBF 与 eGFR 无相关性(r=0.002,P=0.45),静息 MBF 则与 eGFR 呈显著负相关(r=-0.49,P<0.0001)。静息 MBF 也与血红蛋白呈显著负相关(r=-0.28,P=0.014),但多元分析仅显示 eGFR 是唯一的独立相关因素。结论:CKD 患者即使存在正常的区域性灌注和左心室功能,其 MFR 也会受损,这主要是由于静息状态下的血流量增加所致。绝对血流量的定量分析可能有助于识别微脉管功能障碍,从而在这一特定的高危人群中预测临床显性冠心病的发生。